资讯

Eosinophilic asthma is a severe form of asthma ... Some of the symptoms of this type of asthma more closely resemble those of chronic pulmonary obstructive disorder (COPD). Working with your ...
Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.
Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory disease of undetermined pathophysiology that results in dense mucosal eosinophilia and esophageal dysfunction. In childhood ...
Pharmaceutical Technology on MSN16 天
EMA to review GSK’s Nucala for COPD treatment expansion
The EMA has agreed to review GSK’s application to expand Nucala’s use as an add-on maintenance for individuals with COPD.
GSK plc GSK announced that the European Medicines Agency (“EMA”) has accepted for review a regulatory filing, seeking approval for a new indication of its respiratory drug, Nucala (mepolizumab). The ...
as an add-on maintenance treatment for chronic obstructive pulmonary disease (COPD) with an eosinophilic phenotype. By inhibiting IL-5 signaling, mepolizumab reduces the production and survival of ...
AQILION AB (publ) AQILION AB (publ) presents results from a study conducted by the Company together with Professor Evan Dellon after the research group's abstract was approved at this year's Digestive ...